"Our desire was to engage a
program that had specialty knowledge around CKD and ESRD so that we can address
these issues upfront in CKD and help prevent progression to ESRD, which is
always a difficult diagnosis for patients…and certainly becomes problematic
from a morbidity standpoint."
— Mark Steffen, M.D., chief medical officer at Blue Cross and
Blue Shield of Minnesota, talked with AIS's RADAR
on Medicare Advantage about the insurer's new value-based kidney
care program with VillageHealth.
Subscribers may read the RADAR on Medicare Advantage article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment